2.4.5. Outcome.
anxiety disorder
SECONDARY
The primary efficacy variables were changes in, the PSS, changes in the cognitive scores in the CANTAB Generalized anxiety disorder (GAD-7) scale, and quality of life from baseline/screening to final visit. The secondary endpoints also included changes in the salivary cortisol, urine serotonin, and dopamine, and serum levels of nitric oxide (NO), glutathione (GSH), and malondialdehyde (MDA). Safety was evaluated by laboratory parameters, and by monitoring any incidence of AEs.